Akoya Biosciences, Inc. (AKYA)
USD 2.45
(-3.54%)
USD 2.45
(-3.54%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -45.63 Million USD | 20.55% |
| 2022 | -58.81 Million USD | -80.29% |
| 2021 | -35.16 Million USD | -330.86% |
| 2020 | -10.12 Million USD | 29.42% |
| 2019 | -9.62 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -9.07 Million USD | 54.31% |
| 2024 Q1 | -14.98 Million USD | -191.95% |
| 2023 Q4 | -6.71 Million USD | 47.51% |
| 2023 FY | - USD | 20.55% |
| 2023 Q3 | -12.79 Million USD | 21.18% |
| 2023 Q2 | -16.23 Million USD | -11.79% |
| 2023 Q1 | -14.52 Million USD | 1.87% |
| 2022 Q2 | -16.07 Million USD | -16.44% |
| 2022 Q1 | -13.8 Million USD | 5.09% |
| 2022 FY | - USD | -80.29% |
| 2022 Q4 | -14.79 Million USD | -1.56% |
| 2022 Q3 | -14.57 Million USD | 9.38% |
| 2021 Q1 | -4 Million USD | -208.4% |
| 2021 FY | - USD | -330.86% |
| 2021 Q4 | -14.54 Million USD | -54.83% |
| 2021 Q3 | -9.39 Million USD | -91.89% |
| 2021 Q2 | -4.89 Million USD | -22.43% |
| 2020 FY | - USD | 29.42% |
| 2020 Q4 | -1.29 Million USD | 31.74% |
| 2020 Q3 | -1.9 Million USD | 17.78% |
| 2020 Q2 | -2.31 Million USD | -8.5% |
| 2020 Q1 | -2.13 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AngioDynamics, Inc. | -14.29 Million USD | -219.284% |
| AtriCure, Inc. | -8.1 Million USD | -462.733% |
| Avinger, Inc. | -16.34 Million USD | -179.163% |
| Azenta, Inc. | 55.15 Million USD | 182.74% |
| BioLife Solutions, Inc. | -45.23 Million USD | -0.871% |
| The Cooper Companies, Inc. | 882.8 Million USD | 105.169% |
| Daxor Corporation | 329.74 Thousand USD | 13938.782% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | -245.749% |
| Femasys Inc. | -13.16 Million USD | -246.5% |
| GlucoTrack, Inc. | -7.09 Million USD | -543.52% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 580.691% |
| Hologic, Inc. | 1.29 Billion USD | 103.52% |
| ICU Medical, Inc. | 307.69 Million USD | 114.83% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 101.906% |
| KORU Medical Systems, Inc. | -9.39 Million USD | -385.468% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 193.146% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -594.009% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -594.009% |
| Masimo Corporation | 236.7 Million USD | 119.278% |
| Microbot Medical Inc. | -10.63 Million USD | -329.114% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 389.349% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 119.716% |
| Nephros, Inc. | -1.37 Million USD | -3209.065% |
| NovoCure Limited | -175.86 Million USD | 74.053% |
| NEXGEL, Inc. | -2.73 Million USD | -1571.502% |
| NEXGEL, Inc. | -2.73 Million USD | -1571.502% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 47.244% |
| OraSure Technologies, Inc. | 76.15 Million USD | 159.918% |
| Pro-Dex, Inc. | 8.33 Million USD | 647.606% |
| Pulse Biosciences, Inc. | -42.36 Million USD | -7.706% |
| Predictive Oncology Inc. | -13.18 Million USD | -246.169% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | -1716.596% |
| QuidelOrtho Corporation | 545.6 Million USD | 108.364% |
| Repligen Corporation | 124.29 Million USD | 136.714% |
| Sanara MedTech Inc. | -289.09 Thousand USD | -15684.322% |
| STAAR Surgical Company | 33.22 Million USD | 237.359% |
| Sharps Technology, Inc. | -8.98 Million USD | -408.129% |
| Utah Medical Products, Inc. | 24.8 Million USD | 283.963% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 119.669% |
| Jin Medical International Ltd. | 3.44 Million USD | 1425.4% |